• Topics

  • Formats

Organiser: EMJ GOLD
As we approach the end of Pride month, Jade explores how the pharmaceutical industry can best staff and patients who identify as part of the LGBTQ+ community. She talks with Edmond Chan, Senior Director, EMEA Therapeutic Area Lead, Haemato-Oncology, Johnson & Johnson, who shares his personal views on how the industry can improve health outcomes and encourage authenticity.

In this interview, they discuss how both the pharmaceutical and healthcare industries can do their best to support people from the LGBTQ+ community, the unique challenges that patients and staff may face and more.

A little more on GOLD’s guest…

Edmond has been with J&J for just over ten years, starting in pharmacovigilance before moving into medical affairs. During this time, he has worked in the areas of diabetes and immunology before recently settling into his current area of expertise, haemato-oncology.

Edmond also works as an ABPI final signatory and holds a PhD in Medical Research in Therapeutic Antibodies as well as a Masters in Medical Statistics. He also has 12 years’ experience in clinical practice.

At the heart of all these academic and professional achievements, Ed is also a proud member of the LGBTQ+ community and strives to be a role model for other members.

You are attempting to log out of MyMA

Do you really want to log out?